STOCK TITAN

Venus Concept to Release Fourth Quarter and Fiscal Year 2022 Financial Results on March 27, 2023

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Venus Concept (NASDAQ: VERO) will release its fourth quarter and fiscal year 2022 financial results on March 27, 2023, before the market opens. Management will conduct a conference call at 8:00 a.m. ET the same day to discuss the results and answer questions. Interested participants can join by phone or via a live webcast on the company's investor relations website. Those unable to attend can access a replay for two weeks following the call. Venus Concept specializes in innovative medical aesthetic technology and has a presence in over 60 countries, offering a wide range of minimally invasive and non-invasive products.

Positive
  • None.
Negative
  • None.

TORONTO, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that fourth quarter and fiscal year 2022 financial results will be released before the market opens on Monday, March 27, 2023.

Management will host a conference call at 8:00 a.m. Eastern Time on March 27, 2023 to discuss the results of the quarter and the year with a question and answer session. Those who would like to participate may dial 877-407-2991 (201-389-0925 for international callers) and provide access code 13736286. A live webcast of the call will also be provided on the investor relations section of the Company's website at ir.venusconcept.com.

For those unable to participate, a replay of the call will be available for two weeks at 877-660-6853 (201-612-7415 for international callers); access code 13736286. The webcast will be archived at ir.venusconcept.com.

About Venus Concept

Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reach in over 60 countries and 16 direct markets. Venus Concept’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Viva, Venus Glow, Venus Bliss, Venus BlissMAX, Venus Epileve, Venus Viva MD and AI.ME. Venus Concept’s hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. Venus Concept has been backed by leading healthcare industry growth equity investors including EW Healthcare Partners (formerly Essex Woodlands), HealthQuest Capital, Longitude Capital Management, Aperture Venture Partners, and Masters Special Situations.


FAQ

When will Venus Concept release its fourth quarter and fiscal year 2022 financial results?

Venus Concept will release its financial results on March 27, 2023, before the market opens.

What time is the conference call for Venus Concept's financial results?

The conference call will take place at 8:00 a.m. Eastern Time on March 27, 2023.

How can I participate in the Venus Concept conference call?

You can participate by dialing 877-407-2991 or 201-389-0925 for international callers, providing access code 13736286.

Will there be a replay of the Venus Concept conference call?

Yes, a replay will be available for two weeks at 877-660-6853 or 201-612-7415 for international callers.

Where can I find the webcast for the Venus Concept conference call?

The webcast will be available on the investor relations section of Venus Concept's website.

Venus Concept Inc.

NASDAQ:VERO

VERO Rankings

VERO Latest News

VERO Stock Data

2.18M
6.70M
6.08%
27.03%
19.95%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
TORONTO